Vertesi reported a Risk Assessment Stratification Protocol (RASP) for determining the severity of a possible exposure to HIV. This can help to determine if a patient should receive post-exposure prophylaxis. The author is from Royal Columbian Hospital in British Columbia.
Parameters:
(1) source
(2) inoculum type
(3) method of transmission
(4) estimated volume of onoculum
Parameter |
Finding |
Points |
source |
HIV positive with acute AIDs illness |
1 |
|
HIV positive, asymptomatic |
10 |
|
unknown HIV status, high risk |
100 |
|
unknown HIV status, low risk |
1000 |
inoculum |
fresh blood |
1 |
|
high-risk body fluid (semen, etc) |
10 |
|
dried old blood |
100 |
|
low risk secretion (tears, saliva, urine) |
1000 |
method of transmission |
intravenous |
1 |
|
deep intramuscular |
10 |
|
deep transcutaneous with visible bleeding at site |
100 |
|
superficial transcutaneous with no visible bleeding |
200 |
|
mucosal contact only |
500 |
|
intact skin |
1000 |
volume of inoculum |
massive (blood transfusion) |
100 |
|
> 1 mL |
10 |
|
large-bore hollow needle larger than 22 gauge |
5 |
|
small-bore hollow needle 22 gauge or less |
3 |
|
1 |
where:
• A high-risk source includes suspected HIV, injection drug user, high local prevalence of HIV
basic risk =
= 1 / ((points for source) * (points for inoculum) * (points for method of transmission))
total risk =
= (volume of inoculum) * (basic risk)
Interpretation:
• minimum basic risk: 1 in 10^9
• maximum basic risk: 1 in 1
• minimum total risk: 1 in 10^9
• maximum total risk: 100
Total Risk |
Prophylaxis |
greater than 1 in 1000 |
indicated |
1 in a 1000 to 1 in 10,000 |
recommended |
1 in 10,001 to 1 in 100,000 |
optional but not recommended |
less than 1 in 100,000 |
no indicated |
Specialty: Infectious Diseases